This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Shashi Jatiani
Director of Research at Seromyx Systems


Shashi Jatiani completed his Ph.D. in Molecular Biology from India’s Tata Institute for Fundamental Research (TIFR), did his postdoctoral training in Cancer Therapeutics from Temple University’s Fels Institute for Cancer Research in Philadelphia, and served as Instructor of Oncological Sciences and Assistant Professor of Pharmacological Sciences at Icahn School of Medicine at Mount Sinai, New York. In the biotech setting Shashi’s work as Principal Scientist at Valo Health and Nested Therapeutics resulted in DC nomination and the initiation of IND-enabling studies.

Agenda Sessions

  • Unlocking the Potential of the Fc for More Effective Therapeutic Antibody Products